Maintaining Optimal Trauma Outcomes: Resilience in the Midst of a Ransomware Attack
NCT ID: NCT04881279
Last Updated: 2023-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
846 participants
OBSERVATIONAL
2017-04-01
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Retrospective review of de-identified hospital emergency room and trauma registry data and operating room case logs from April 9th through June 9th, 2016, 2017, and 2018. Baseline characteristics of study cohort for each period will be examined using the chi-square test for categorical variables and the Student's t-test for continuous variables that are normally distributed.
This was an exempt study in our institution.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Trauma admissions in April-June 2016.
No interventions assigned to this group
Ransomware Group
Trauma admissions in April-June 2017.
Event
Ransomware attack
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Event
Ransomware attack
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients \>13 years old
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weidun Alan Guo, MD, PhD
Department of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
W. Alan Guo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
State University of Buffalo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erie County Medical Center
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00002779
Identifier Type: -
Identifier Source: org_study_id